Eucrates Biomedical Acquisition Statistics Share Statistics Eucrates Biomedical Acquisition has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.59M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 357, so 0% of the outstanding
shares have been sold short.
Short Interest 357 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 999.99
Valuation Ratios The PE ratio is 5.37 and the forward
PE ratio is null.
Eucrates Biomedical Acquisition's PEG ratio is
0.12.
PE Ratio 5.37 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 3.49 P/FCF Ratio -47.22 PEG Ratio 0.12
Financial Ratio History Enterprise Valuation Eucrates Biomedical Acquisition has an Enterprise Value (EV) of 29.8M.
EV / Sales 0 EV / EBITDA -11.57 EV / EBIT -47.28 EV / FCF -47.28
Financial Position The company has a current ratio of 2.03,
with a Debt / Equity ratio of 0.01.
Current Ratio 2.03 Quick Ratio 2.03 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.1 Interest Coverage 0
Financial Efficiency Return on Equity is 64.88% and Return on Invested Capital is -12.88%.
Return on Equity 64.88% Return on Assets 44.36% Return on Invested Capital -12.88% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -3.12M Effective Tax Rate -128.84%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is -0.07, so Eucrates Biomedical Acquisition's
price volatility has been lower than the market average.
Beta -0.07 52-Week Price Change n/a 50-Day Moving Average 10.29 200-Day Moving Average 10.07 Relative Strength Index (RSI) 15.57 Average Volume (20 Days) 581
Income Statement
Revenue n/a Gross Profit n/a Operating Income -699K Net Income 5.54M EBITDA -2.58M EBIT -699K Earnings Per Share (EPS) 1.86
Full Income Statement Balance Sheet The company has 18.86K in cash and 60.06K in
debt, giving a net cash position of -41.2K.
Cash & Cash Equivalents 18.86K Total Debt 60.06K Net Cash -41.2K Retained Earnings -3.72M Total Assets 12.49M Working Capital 67.06K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -630.29K
and capital expenditures 0, giving a free cash flow of -630.29K.
Operating Cash Flow -630.29K Capital Expenditures n/a Free Cash Flow -630.29K FCF Per Share -0.21
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a